Eczemol NDC 61480-127

NDC codes

FDA NDC Directory

Product NDC (as listed)61480-127Labeler and product segments. Claims need a package NDC.

Product NDC at billing width61480-0127Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
61480-127-05	61480012705	100 TABLET in 1 BOTTLE (61480-127-05)Marketed from Nov 15, 2001

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Eczemol
Generic name (nonproprietary): potassium bromide, nickel sulfate, and sulfur
Active ingredients: Potassium bromide — 1 [hp_X]/1Nickel sulfate — 1 [hp_X]/1Sulfur — 1 [hp_X]/1
Dosage form: Tablet
Route: Oral
Labeler: PLYMOUTH HEALTHCARE PRODUCTS LLC
Product type: Prescription drug
Marketing category: Unapproved homeopathic
Marketing start: Nov 15, 2001
Listing expires: Dec 31, 2026
Identifiers: Product ID 61480-127_440c8a06-8ffb-f7af-e063-6394a90a7ccfSPL ID 440c8a06-8ffb-f7af-e063-6394a90a7ccfSPL set ID 981e9f3d-b608-4a5e-92f8-895b22da12f4UNII OSD78555ZM, 4FLT4T3WUN, 70FD1KFU70UPC 0361480127053

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N461480012705 followed by a unit qualifier and the quantity

Package 61480-0127-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Nov 20, 2025.

Indications (excerpt from the label)

INDICATIONS ECZEMOL ® is indicated for the treatment of moderate to severe eczema and atopic dermatitis. It has been found to work well with a variety of combination therapies.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)